You still don't want to get Parkinsons so ask your competent? doctor for EXACT PROTOCOLS TO PREVENT THAT!
Parkinson’s Disease May Have Link to Stroke March 2017
Your doctor is then required to have EXACT PROTOCOLS that prevent Parkinsons. Your doctor has no excuses for not having EXACT PARKINSONS PREVENTION PROTOCOLS! 7 years is plenty of time for competent doctors to come up with those protocols, especially since thousands of doctors need those protocols! But since there is NO leadership in stroke, NOTHING ever gets done!
How coffee protects against Parkinson’s Aug. 2014
10 years for your competent? doctor to come up with EXACT AMOUNTS OF COFFEE TO DRINK DAILY. Your incompetent doctors didn't do that, did they?
My Dad got Parkinson's dementia and didn't even know me the last three years.
The latest here:
Lower Dementia Risk Than Previously Thought in Parkinson’s
Summary: A new study suggests that the risk of developing dementia in Parkinson’s disease patients may be lower or occur later than previously reported. Researchers analyzed data from two large studies, finding a 9% risk of dementia within 10 years for newly diagnosed patients and a 27% risk for those diagnosed for an average of six years. Factors increasing dementia risk included older age at diagnosis, being male, and lower education levels.
Key facts:
- 9% risk of dementia 10 years after Parkinson’s diagnosis (newly diagnosed patients).
- 27% risk of dementia 10 years after Parkinson’s diagnosis (patients diagnosed for an average of six years).
- Higher dementia risk with older age at diagnosis, being male, and lower education levels.
Source: AAN
There’s some good news for people with Parkinson’s disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course of the disease than previously reported, according to a study published in the August 7, 2024, online issue of Neurology.
“The development of dementia is feared by people with Parkinson’s, and the combination of both a movement disorder and a cognitive disorder can be devastating to them and their loved ones,” said study author Daniel Weintraub, MD, of the University of Pennsylvania in Philadelphia.
“These results provide more hopeful estimates of the long-term risk of dementia for people with Parkinson’s disease, suggesting that there is a longer window to intervene to prevent or delay cognitive decline.”
Previous studies had indicated that about 80% of people with Parkinson’s disease would develop dementia within 15-20 years after being diagnosed with Parkinson’s.
“While these studies were important in highlighting the issue of cognitive decline in Parkinson’s disease, the studies were conducted many years ago, were relatively small and had other limitations, so we wanted to re-evaluate these findings,” Weintraub said.
For the study, researchers analyzed data from two large, prospective studies. An international study involved 417 participants with an average age of 62 who were newly diagnosed with Parkinson’s disease and had not yet received treatment for the disease at study enrollment.
A study at the University of Pennsylvania involved 389 people with Parkinson’s with an average age of 69 who had been diagnosed with Parkinson’s an average of six years before the start of the study. The participants were followed to see whether they developed dementia.
The international study showed an estimated probability of being diagnosed with dementia 10 years after being diagnosed with Parkinson’s disease of 9%. For the Pennsylvania study, the probability of being diagnosed with dementia 10 years after the Parkinson’s diagnosis was 27%. For the latter study, researchers found an estimated risk of dementia at 50%, 15 years after a Parkinson’s diagnosis and 74%, 20 years after diagnosis.
Factors that increased the risk of dementia in the Pennsylvania study included being older when Parkinson’s was diagnosed, being male and having a lower level of education.
A limitation of both studies is that participants were highly educated, mainly white people and were recruited for participation in a research study, so they may not represent the general population.
Funding: The international study, the Parkinson’s Progression Markers Initiative, is a public-private partnership funded by the Michael J. Fox Foundation for Parkinson’s Research and numerous funding partners. The University of Pennsylvania study was supported by the National Institute on Aging.
About this Parkinson’s disease research news
Author: Renee Tessman
Source: AAN
Contact: Renee Tessman – AAN
Image: The image is credited to Neuroscience News
Original Research: The findings will appear in Neurology
No comments:
Post a Comment